0001209191-23-019599.txt : 20230317 0001209191-23-019599.hdr.sgml : 20230317 20230317160519 ACCESSION NUMBER: 0001209191-23-019599 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230315 FILED AS OF DATE: 20230317 DATE AS OF CHANGE: 20230317 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Borgman Anne Elizabeth CENTRAL INDEX KEY: 0001886388 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38662 FILM NUMBER: 23742513 MAIL ADDRESS: STREET 1: 9000 VIRGINIA MANOR ROAD STREET 2: SUITE 200 CITY: BELTSVILLE STATE: MD ZIP: 20705 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SUTRO BIOPHARMA, INC. CENTRAL INDEX KEY: 0001382101 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 452441988 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 111 OYSTER POINT BLVD. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-392-8412 MAIL ADDRESS: STREET 1: 111 OYSTER POINT BLVD. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: SUTRO BIOPHARMA INC DATE OF NAME CHANGE: 20061127 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-03-15 0 0001382101 SUTRO BIOPHARMA, INC. STRO 0001886388 Borgman Anne Elizabeth C/O SUTRO BIOPHARMA, INC. 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 0 1 0 0 Chief Medical Officer Stock Option (right to buy Common Stock) 5.40 2023-03-15 4 A 0 175000 0.00 A 2033-02-27 Common Stock 175000 175000 D Restricted Stock Unit (RSU) 2023-03-15 4 A 0 150000 0.00 A 2027-02-28 Common Stock 150000 150000 D The option vests as to 1/4th of the total shares on February 28, 2024 and then 1/48th of the total shares vest monthly thereafter, with 100% of the total shares vested and exercisable on February 28, 2027, subject to the reporting person's provision of service to the issuer on each vesting date. Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement. The RSUs vest as to 1/4th of the total shares annually beginning on February 28, 2024, subject to continued service through each vesting date. /s/ Edward C. Albini as attorney-in-fact for Anne E. Borgman 2023-03-17